Terms: = Liver cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76
50321 results:
1. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.
Xiong SP; Wang CH; Zhang MF; Yang X; Yun JP; Liu LL
J Transl Med; 2024 May; 22(1):472. PubMed ID: 38762511
[TBL] [Abstract] [Full Text] [Related]
2. Mortality outcomes in diabetic metabolic dysfunction-associated fatty liver disease: non-obese versus obese individuals.
Zhang P; Zeng Y; Yang S; Ye C; Wang M; Peng T; Li L; Dong X
Sci Rep; 2024 May; 14(1):11320. PubMed ID: 38760435
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
4. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract] [Full Text] [Related]
6.
Xiao X; Zhou Y; Li X; Jin J; Durham J; Ye Z; Wang Y; Hennig B; Deng P
Microbiome; 2024 May; 12(1):90. PubMed ID: 38750595
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract] [Full Text] [Related]
8. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
[TBL] [Abstract] [Full Text] [Related]
9. LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes.
Ding J; Nguyen AT; Lohman K; Hensley MT; Parker D; Hou L; Taylor J; Voora D; Sawyer JK; Boudyguina E; Bancks MP; Bertoni A; Pankow JS; Rotter JI; Goodarzi MO; Tracy RP; Murdoch DM; Rich SS; Psaty BM; Siscovick D; Newgard C; Herrington D; Hoeschele I; Shea S; Stein JH; Patel M; Post W; Jacobs D; Parks JS; Liu Y
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747290
[TBL] [Abstract] [Full Text] [Related]
10. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.
Wong RJ; Jones PD; Niu B; Therapondos G; Thamer M; Kshirsagar O; Zhang Y; Pinheiro P; Kyalwazi B; Fass R; Khalili M; Singal AG
JAMA Netw Open; 2024 May; 7(5):e2411076. PubMed ID: 38743424
[TBL] [Abstract] [Full Text] [Related]
11. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
[No Abstract] [Full Text] [Related]
12. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
13. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
[TBL] [Abstract] [Full Text] [Related]
14. Projected estimates of cancer in Canada in 2024.
Brenner DR; Gillis J; Demers AA; Ellison LF; Billette JM; Zhang SX; Liu JL; Woods RR; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D;
CMAJ; 2024 May; 196(18):E615-E623. PubMed ID: 38740416
[TBL] [Abstract] [Full Text] [Related]
15. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract] [Full Text] [Related]
16. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
[TBL] [Abstract] [Full Text] [Related]
17. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
[TBL] [Abstract] [Full Text] [Related]
18. [Curative effect of percutaneous microwave ablation therapy on hepatocellular carcinoma survival: a 15-year real-world study].
Luo YC; Lang ML; Cai WJ; Han ZY; Liu FY; Cheng ZG; Yu XL; Dou JP; Li X; Tan SL; Dong XJ; Liang P; Yu J
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):332-339. PubMed ID: 38733188
[No Abstract] [Full Text] [Related]
19. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Wang DS; Ren C; Li SS; Fong WP; Wu XJ; Xiao J; Li BK; Zheng Y; Ding PR; Chen G; Qiu MZ; Wang ZQ; Wang FH; Luo HY; Wang F; Wang XZ; Wang LY; Xie DJ; Chen T; Li LR; Lu ZH; Zhai XH; Liu TS; Yuan Y; Chen JQ; Tan Q; Pan ZZ; Wan DS; Zhang R; Yuan YF; Xu RH; Li YH
PLoS Med; 2024 May; 21(5):e1004389. PubMed ID: 38728364
[TBL] [Abstract] [Full Text] [Related]
20. Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Ren S; Xiong A; Yu J; Wang X; Han B; Pan Y; Zhao J; Cheng Y; Hu S; Liu T; Li Y; Cheng Y; Feng J; Yi S; Gu S; Gao S; Luo Y; Liu Y; Liu C; Duan H; Wang S; Yang X; Fan J; Zhou C
Cancer Immunol Immunother; 2024 May; 73(7):124. PubMed ID: 38727837
[TBL] [Abstract] [Full Text] [Related]
[Next]
